Custom Search

Register
Sign In
Sign In Using Facebook

Weight-based Dosage Increases Hepatitis C Treatment Efficacy

by Sreeraman on  December 28, 2007 at 7:32 PM Drug News
  •   Print
  •   Share
  •   Comments
  •  Text 
Weight-based Dosage Increases Hepatitis C Treatment Efficacy
A multicenter study called WIN-R on hepatitis C patients, showed that the treatment with weight-based drugs resulted in improved efficacy and lower relapse rates, mainly in African-Americans with most difficult-to-treat form of the disease.


The study of over 5,000 patients with hepatitis C virus (HCV) showed that the treatment with weight-based REBETOL (ribavirin, USP) (RBV) in combination with pegylated interferon (PEG-IFN) alfa-2b, resulted in higher rates of sustained virologic response (SVR) and lower relapse rates, as compared to combination therapy using a flat dose of RBV 800 mg/day.

The response of such dose was a lot better in patients suffering from the most difficult-to-treat form of the disease, genotype 1 HCV.

However, the efficacy was consistent across all weight groups.

The study was led by Dr. Ira M. Jacobson, the Vincent Astor Professor of Clinical Medicine at Weill Cornell Medical College and chief of the Division of Gastroenterology and Hepatology at NewYork-Presbyterian Hospital/Weill Cornell Medical Center.

For patients infected with genotype 2 or 3, a 24-week course of treatment with flat dose of RBV + PEG-IFN was equally effective as the standard 48-week course, with better tolerability.

In the overall study population, flat dosing of ribavirin was equally effective as weight-based ribavirin.

However, within the flat-dose group of patients with genotypes 2 and 3, sustained response rates showed a slight decline in the higher weight patients who were given flat-dosed ribavirin.

Page 1 Page 1 | 2  Next
 Email Email   RSS Feeds RSS Feeds   Print this page Print   Save this page Save   Link Link   Syndicate Syndicate   Comments Comments   Bookmark and Share
 
Comment & Contribute
Be the first to comment!
Comments should be on the topic and should not be abusive. Comments are normally moderated and are reviewed after they are posted.
* Your comment can be maximum of 2500 characters

Notify me when reply is posted
I agree to the terms and conditions
  

X

Medwonders Health Network

  • Health News Index
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
News Archive
Date :
Category :
Keyword :
  • News Quick Links
News Central Health Watch
Latest Health News Health In Focus
News Category (500+) Breaking Health News
Popular News Celebrating Life
Health News and Press Release Medindia - Exclusive
News Photo Gallery India Special
News Video Gallery Lifestyle and Wellness
News From Other Resources
Hepatitis C
Complete Medindia Resources
News Categories:  
Kidney Health Center

Drug Related News

» Antidepressants and the Risk of Sudden Unexpected Death in Epilepsy » Research Says Financial Burden of Prescription Drugs is Dropping
» New Guidelines to Avoid Heparin Contamination » Weight Loss Drug Has Killed At Least 1,300 in France
» FDA Approves Sanofi’s Treatment for Head Lice » New Scoring Method may Help Decide Who Will Benefit From Stroke Drug
» New Guidelines Recommend Metformin to Treat Type 2 Diabetes » Novel Prostate Cancer Drug Target Identified
Read More >>